Triage News and Research

RSS

A predictive model for COVID-19 outcomes

A new technique to solve unbalanced problems for the efficient management of SARS-CoV-2 infected patients according to comorbidities, age, and sex.

9 Mar 2022

Potential molecular and clinical biomarkers of COVID-19 severity

Researchers have reviewed the currently published data examining the potential molecular and clinical biomarkers of COVID-19 severity.

4 Mar 2022

Study shows the impact of gender-affirming hormone therapy on epigenetic signature of genes

Gender-affirming hormone therapy could influence the way a person's genes are turned on or off, according to a new study.

28 Feb 2022

New prototype sensor aids in the rapid assessment of disease severity

Scientists have developed a prototype sensor that could help doctors rapidly measure adenosine triphosphate (ATP) and lactate levels in blood samples from patients, aiding in the rapid assessment of the severity of some diseases.

25 Feb 2022

Impact of rapid and comprehensive RT-qPCR for detecting SARS-CoV-2 variants of concern

Researchers reported the development and validation of a two-reaction multiplex reverse transcription-quantitative polymerase chain reaction genotyping strategy that distinguishes SARS-CoV-2 variants of concern.

14 Feb 2022

Stroke patients have higher chance of better outcomes when treated at Comprehensive Stroke Centers

When comparing outcomes for acute ischemic stroke patients treated at various levels of stroke centers, patients who received care at Comprehensive Stroke Centers (CSC) or Thrombectomy-capable Stroke Centers (TSC) were more likely to receive rapid treatment with clot-busting medication and/or mechanical clot removal and be discharged home or to rehabilitation centers than patients treated at Primary Stroke Centers, according to preliminary research to be presented today at the American Stroke Association's International Stroke Conference 2022.

12 Feb 2022

New reagent-free SARS-CoV-2 detection technique based on machine learning and Raman spectroscopy

The novel coronavirus, or SARS-CoV-2, which causes the highly contagious COVID-19, has infected millions of people worldwide.

9 Feb 2022

Study suggests hospitalized COVID-19 patients are at higher risk of neurocognitive decline

In a new study, scientists have evaluated patient-reported and clinically tested neuropsychological problems in both ambulatory (outpatients) and hospitalized COVID-19 patients during the early recovery phase.

8 Feb 2022

Study looks at rapid antigen vs. PCR tests in the emergency department triage

In a recent study posted to the Lancet preprint* server, researchers assessed the utility of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) rapid antigen testing (RAT) for patient triage in the hospital emergency department (ED).

7 Feb 2022

A disabled activist speaks out about feeling ‘disposable’

In early January, one of the country's top public health officials went on national television and delivered what she called "really encouraging news" on covid-19: A recent study showed that more than three-fourths of fatalities from the omicron variant of the virus occurred among people with several other medical conditions.

4 Feb 2022

Researchers create model to predict COVID-19 mortality

In a new study, researchers have created a model that can help determine the outcome of COVID-19 infection in patients in the ICU.

31 Jan 2022

Research reveals the burden of aortic valve stenosis in the UK

An estimated 300,000 people in the UK have aortic valve stenosis, a progressive and potentially fatal condition, suggests research published in the open access journal Open Heart.

26 Jan 2022

International study offers a clearer picture of COVID-19's impact on children

A new international study offers a clearer picture of the impact of COVID-19 infection and the risk of severe outcomes on young people around the world.

11 Jan 2022

International approaches to tackling food fraud

In this interview, we spoke to key members of the Food Authenticity Network to find out more about the increasing problem of food adulteration and the collaborations being made to address it.

From Bruker BioSpin Division 11 Jan 2022

New program boosts buprenorphine treatment rates for opioid use disorder

A program designed to increase initiation of buprenorphine treatment for opioid use disorder in the emergency department led to a sixfold increase in its use at three Penn Medicine hospitals, according to new research from the Perelman School of Medicine at the University of Pennsylvania.

23 Dec 2021

Researchers discover biomarker that could aid in early detection of high risk COVID-19 patients

Led by computational researchers from WEHI, in collaboration with The University of Queensland, Queensland University of Technology and Hospital Marcelino Champagnat in Brazil, the study used advanced spatial transcriptomic techniques to screen for genes associated with excessive inflammation in the lungs, a key indicator of severe COVID-19.

7 Dec 2021

Metrion Biosciences expands ion channel drug discovery service capabilities and in-house expertise

Metrion today announced it has expanded its capabilities and expertise through the addition of automated low volume liquid handling capability.

From Metrion Biosciences Limited 7 Dec 2021

Ethics of using hospital resources on unvaccinated-by-choice severe COVID-19 patients

A new opinion piece published online in the Annals of the American Thoracic Society provides an exhaustive examination of the ethics of using hospital resources on unvaccinated-by-choice COVID-19 pneumonia patients, versus patients with other serious illnesses whose diseases are not progressing as quickly.

3 Dec 2021

Role of interferon type I-driven responses associated with disease control in COVID-19

New research suggests that treatment with type I interferons in the early stage of COVID-19 may supress disease progression by limiting SARS-CoV-2 in hosts.

1 Dec 2021

California joins states trying to shorten wait times for mental health care

When Greta Christina fell into a deep depression five years ago, she called up her therapist in San Francisco. She’d had a great connection with the provider when she needed therapy in the past. She was delighted to learn that he was now “in network” with her insurance company, meaning she wouldn’t have to pay out-of-pocket anymore to see him.

29 Nov 2021